共 50 条
- [1] The clinical outcomes and healthcare resource utilization in IgG4-related disease: a claims-based analysis of commercially insured adults in the United States [J]. RHEUMATOLOGY, 2024, 63 (09): : 2457 - 2466
- [6] Healthcare Utilization and Cost Burden of Porphyria in Commercially Insured Adults in the United States [J]. PharmacoEconomics - Open, 2021, 5 : 89 - 100
- [8] Clinical Manifestations and Long-term Outcomes of IgG4-Related Kidney and Retroperitoneal Involvement in a United Kingdom IgG4-Related Disease Cohort [J]. KIDNEY INTERNATIONAL REPORTS, 2019, 4 (01): : 48 - 58